With that said, we should notice that no controls were performed as this was not a randomized, double-blind, placebo-controlled trial, but rather an analysis of the manufacturer's patient registry. So perhaps these hypogonadal non-responders to PDE5 inhibitors might have reported an improvement in their erectile function w/any other form or brand of testosterone. Or perhaps they just needed to bump their testosterone levels high enough for their individual physiology (given the wide range of levels at study end).
Regardless, I think that it's imperative that when presented w/someone complaining of erectile dysfunction, rather than reflexively reaching for the little blue pill, we take a look at the bigger picture: overall health, eg diabetes, heart disease, hypertension, depression, etc; medication side effects, eg blood pressure lowering drugs, antidepressants, etc; mental & emotional factors, eg relationship w/partner, family & friends, financial stability or lack thereof, other stressors, etc.
Follow @alvinblin
|
Write a comment:
|